Trustmark (NASDAQ:TRMK) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.57 by 19.3 percent. This is a 61.9 percent increase over earnings of $0.42 per share from the same period last year.
ContraFect Announces Lopsided Interim Results From Pivotal Bacterial Infection Study
ContraFect Corporation (NASDAQ:CFRX) has announced the database lock of its Phase 3 DISRUPT study of exebacase in patients with Staph…